Raymond James Financial Inc Cognition Therapeutics Inc Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 17,500 shares of CGTX stock, worth $11,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,500Holding current value
$11,550% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
48Shares Held
7.08MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.46 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$820,0850.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$405,5630.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$330,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA324KShares$213,6040.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $15M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...